The global Epirubicin Hydrochloride Injection market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Epirubicin Hydrochloride Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Epirubicin Hydrochloride Injection market size and forecasts, in consumption value ($ Million), sales quantity (K L), and average selling prices (US$/L), 2020-2031
Global Epirubicin Hydrochloride Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K L), and average selling prices (US$/L), 2020-2031
Global Epirubicin Hydrochloride Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K L), and average selling prices (US$/L), 2020-2031
Global Epirubicin Hydrochloride Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K L), and ASP (US$/L), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Epirubicin Hydrochloride Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Epirubicin Hydrochloride Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Akorn, Aurobindo Pharma, Cipla, Ebewe Pharma, Fresenius Kabi Usa, Impax Laboratories, Mylan Laboratories, Nippon Kayaku, Pfizer, Sawai Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Epirubicin Hydrochloride Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
5mg
10mg
Market segment by Application
Leukemia
Malignant Lymphoma
Multiple Myeloma
Breast Cancer
Lung Cancer
Soft Tissue Sarcoma
Stomach Cancer
Colorectal Cancer
Ovarian Cancer
Others
Major players covered
Akorn
Aurobindo Pharma
Cipla
Ebewe Pharma
Fresenius Kabi Usa
Impax Laboratories
Mylan Laboratories
Nippon Kayaku
Pfizer
Sawai Pharmaceutical
Zennova
Beijing Union Pharmaceutical Factory
Hisun Pharmaceutical
Hanhui Pharmaceutical
Lunan Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Epirubicin Hydrochloride Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Epirubicin Hydrochloride Injection, with price, sales quantity, revenue, and global market share of Epirubicin Hydrochloride Injection from 2020 to 2025.
Chapter 3, the Epirubicin Hydrochloride Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Epirubicin Hydrochloride Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Epirubicin Hydrochloride Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Epirubicin Hydrochloride Injection.
Chapter 14 and 15, to describe Epirubicin Hydrochloride Injection sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Epirubicin Hydrochloride Injection Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 5mg
1.3.3 10mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Epirubicin Hydrochloride Injection Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Leukemia
1.4.3 Malignant Lymphoma
1.4.4 Multiple Myeloma
1.4.5 Breast Cancer
1.4.6 Lung Cancer
1.4.7 Soft Tissue Sarcoma
1.4.8 Stomach Cancer
1.4.9 Colorectal Cancer
1.4.10 Ovarian Cancer
1.5 Global Epirubicin Hydrochloride Injection Market Size & Forecast
1.5.1 Global Epirubicin Hydrochloride Injection Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Epirubicin Hydrochloride Injection Sales Quantity (2020-2031)
1.5.3 Global Epirubicin Hydrochloride Injection Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Akorn
2.1.1 Akorn Details
2.1.2 Akorn Major Business
2.1.3 Akorn Epirubicin Hydrochloride Injection Product and Services
2.1.4 Akorn Epirubicin Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Akorn Recent Developments/Updates
2.2 Aurobindo Pharma
2.2.1 Aurobindo Pharma Details
2.2.2 Aurobindo Pharma Major Business
2.2.3 Aurobindo Pharma Epirubicin Hydrochloride Injection Product and Services
2.2.4 Aurobindo Pharma Epirubicin Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Aurobindo Pharma Recent Developments/Updates
2.3 Cipla
2.3.1 Cipla Details
2.3.2 Cipla Major Business
2.3.3 Cipla Epirubicin Hydrochloride Injection Product and Services
2.3.4 Cipla Epirubicin Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Cipla Recent Developments/Updates
2.4 Ebewe Pharma
2.4.1 Ebewe Pharma Details
2.4.2 Ebewe Pharma Major Business
2.4.3 Ebewe Pharma Epirubicin Hydrochloride Injection Product and Services
2.4.4 Ebewe Pharma Epirubicin Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Ebewe Pharma Recent Developments/Updates
2.5 Fresenius Kabi Usa
2.5.1 Fresenius Kabi Usa Details
2.5.2 Fresenius Kabi Usa Major Business
2.5.3 Fresenius Kabi Usa Epirubicin Hydrochloride Injection Product and Services
2.5.4 Fresenius Kabi Usa Epirubicin Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Fresenius Kabi Usa Recent Developments/Updates
2.6 Impax Laboratories
2.6.1 Impax Laboratories Details
2.6.2 Impax Laboratories Major Business
2.6.3 Impax Laboratories Epirubicin Hydrochloride Injection Product and Services
2.6.4 Impax Laboratories Epirubicin Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Impax Laboratories Recent Developments/Updates
2.7 Mylan Laboratories
2.7.1 Mylan Laboratories Details
2.7.2 Mylan Laboratories Major Business
2.7.3 Mylan Laboratories Epirubicin Hydrochloride Injection Product and Services
2.7.4 Mylan Laboratories Epirubicin Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Mylan Laboratories Recent Developments/Updates
2.8 Nippon Kayaku
2.8.1 Nippon Kayaku Details
2.8.2 Nippon Kayaku Major Business
2.8.3 Nippon Kayaku Epirubicin Hydrochloride Injection Product and Services
2.8.4 Nippon Kayaku Epirubicin Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Nippon Kayaku Recent Developments/Updates
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Epirubicin Hydrochloride Injection Product and Services
2.9.4 Pfizer Epirubicin Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Pfizer Recent Developments/Updates
2.10 Sawai Pharmaceutical
2.10.1 Sawai Pharmaceutical Details
2.10.2 Sawai Pharmaceutical Major Business
2.10.3 Sawai Pharmaceutical Epirubicin Hydrochloride Injection Product and Services
2.10.4 Sawai Pharmaceutical Epirubicin Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Sawai Pharmaceutical Recent Developments/Updates
2.11 Zennova
2.11.1 Zennova Details
2.11.2 Zennova Major Business
2.11.3 Zennova Epirubicin Hydrochloride Injection Product and Services
2.11.4 Zennova Epirubicin Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Zennova Recent Developments/Updates
2.12 Beijing Union Pharmaceutical Factory
2.12.1 Beijing Union Pharmaceutical Factory Details
2.12.2 Beijing Union Pharmaceutical Factory Major Business
2.12.3 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Injection Product and Services
2.12.4 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Beijing Union Pharmaceutical Factory Recent Developments/Updates
2.13 Hisun Pharmaceutical
2.13.1 Hisun Pharmaceutical Details
2.13.2 Hisun Pharmaceutical Major Business
2.13.3 Hisun Pharmaceutical Epirubicin Hydrochloride Injection Product and Services
2.13.4 Hisun Pharmaceutical Epirubicin Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Hisun Pharmaceutical Recent Developments/Updates
2.14 Hanhui Pharmaceutical
2.14.1 Hanhui Pharmaceutical Details
2.14.2 Hanhui Pharmaceutical Major Business
2.14.3 Hanhui Pharmaceutical Epirubicin Hydrochloride Injection Product and Services
2.14.4 Hanhui Pharmaceutical Epirubicin Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Hanhui Pharmaceutical Recent Developments/Updates
2.15 Lunan Pharmaceutical
2.15.1 Lunan Pharmaceutical Details
2.15.2 Lunan Pharmaceutical Major Business
2.15.3 Lunan Pharmaceutical Epirubicin Hydrochloride Injection Product and Services
2.15.4 Lunan Pharmaceutical Epirubicin Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Lunan Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Epirubicin Hydrochloride Injection by Manufacturer
3.1 Global Epirubicin Hydrochloride Injection Sales Quantity by Manufacturer (2020-2025)
3.2 Global Epirubicin Hydrochloride Injection Revenue by Manufacturer (2020-2025)
3.3 Global Epirubicin Hydrochloride Injection Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Epirubicin Hydrochloride Injection by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Epirubicin Hydrochloride Injection Manufacturer Market Share in 2024
3.4.3 Top 6 Epirubicin Hydrochloride Injection Manufacturer Market Share in 2024
3.5 Epirubicin Hydrochloride Injection Market: Overall Company Footprint Analysis
3.5.1 Epirubicin Hydrochloride Injection Market: Region Footprint
3.5.2 Epirubicin Hydrochloride Injection Market: Company Product Type Footprint
3.5.3 Epirubicin Hydrochloride Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Epirubicin Hydrochloride Injection Market Size by Region
4.1.1 Global Epirubicin Hydrochloride Injection Sales Quantity by Region (2020-2031)
4.1.2 Global Epirubicin Hydrochloride Injection Consumption Value by Region (2020-2031)
4.1.3 Global Epirubicin Hydrochloride Injection Average Price by Region (2020-2031)
4.2 North America Epirubicin Hydrochloride Injection Consumption Value (2020-2031)
4.3 Europe Epirubicin Hydrochloride Injection Consumption Value (2020-2031)
4.4 Asia-Pacific Epirubicin Hydrochloride Injection Consumption Value (2020-2031)
4.5 South America Epirubicin Hydrochloride Injection Consumption Value (2020-2031)
4.6 Middle East & Africa Epirubicin Hydrochloride Injection Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global Epirubicin Hydrochloride Injection Sales Quantity by Type (2020-2031)
5.2 Global Epirubicin Hydrochloride Injection Consumption Value by Type (2020-2031)
5.3 Global Epirubicin Hydrochloride Injection Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Epirubicin Hydrochloride Injection Sales Quantity by Application (2020-2031)
6.2 Global Epirubicin Hydrochloride Injection Consumption Value by Application (2020-2031)
6.3 Global Epirubicin Hydrochloride Injection Average Price by Application (2020-2031)
7 North America
7.1 North America Epirubicin Hydrochloride Injection Sales Quantity by Type (2020-2031)
7.2 North America Epirubicin Hydrochloride Injection Sales Quantity by Application (2020-2031)
7.3 North America Epirubicin Hydrochloride Injection Market Size by Country
7.3.1 North America Epirubicin Hydrochloride Injection Sales Quantity by Country (2020-2031)
7.3.2 North America Epirubicin Hydrochloride Injection Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe Epirubicin Hydrochloride Injection Sales Quantity by Type (2020-2031)
8.2 Europe Epirubicin Hydrochloride Injection Sales Quantity by Application (2020-2031)
8.3 Europe Epirubicin Hydrochloride Injection Market Size by Country
8.3.1 Europe Epirubicin Hydrochloride Injection Sales Quantity by Country (2020-2031)
8.3.2 Europe Epirubicin Hydrochloride Injection Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Epirubicin Hydrochloride Injection Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Epirubicin Hydrochloride Injection Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Epirubicin Hydrochloride Injection Market Size by Region
9.3.1 Asia-Pacific Epirubicin Hydrochloride Injection Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Epirubicin Hydrochloride Injection Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America Epirubicin Hydrochloride Injection Sales Quantity by Type (2020-2031)
10.2 South America Epirubicin Hydrochloride Injection Sales Quantity by Application (2020-2031)
10.3 South America Epirubicin Hydrochloride Injection Market Size by Country
10.3.1 South America Epirubicin Hydrochloride Injection Sales Quantity by Country (2020-2031)
10.3.2 South America Epirubicin Hydrochloride Injection Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Epirubicin Hydrochloride Injection Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Epirubicin Hydrochloride Injection Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Epirubicin Hydrochloride Injection Market Size by Country
11.3.1 Middle East & Africa Epirubicin Hydrochloride Injection Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Epirubicin Hydrochloride Injection Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 Epirubicin Hydrochloride Injection Market Drivers
12.2 Epirubicin Hydrochloride Injection Market Restraints
12.3 Epirubicin Hydrochloride Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Epirubicin Hydrochloride Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Epirubicin Hydrochloride Injection
13.3 Epirubicin Hydrochloride Injection Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Epirubicin Hydrochloride Injection Typical Distributors
14.3 Epirubicin Hydrochloride Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Akorn
Aurobindo Pharma
Cipla
Ebewe Pharma
Fresenius Kabi Usa
Impax Laboratories
Mylan Laboratories
Nippon Kayaku
Pfizer
Sawai Pharmaceutical
Zennova
Beijing Union Pharmaceutical Factory
Hisun Pharmaceutical
Hanhui Pharmaceutical
Lunan Pharmaceutical
听
听
*If Applicable.
